Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up-Reference-Cited by-同舟云学术

Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up

Published:2016-03-03 Issue:6 Volume:32 Page:615-622
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab Res Rev

Author:

Huang Gan¹,Yin Min¹,Xiang Yufei¹,Li Xia¹,Shen Wei¹,Luo Shuoming¹,Lin Jian¹,Xie Zhiguo¹,Zheng Peilin¹,Zhou Zhiguang¹

Affiliation:

1. Institute of Metabolism and Endocrinology, The Second Xiangya Hospital, Key Laboratory of Diabetes Immunology, Ministry of Education, Central South University; National Clinical Research Centre for Metabolic Diseases; Changsha Hunan 410011 China

Funder

National Key Technology R&D Programme

National Clinical Research Centre for Metabolic Disease

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/dmrr.2779/fullpdf

Reference23 articles.

1. LADA and CARDS: a prospective study of clinical outcome in established adult-onset autoimmune diabetes;Hawa;Diabetes Care,2014

2. Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapy;Guglielmi;Diabetes Metab Res Rev,2012